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Posttranslational modifications of histone amino Results and discussion
Recent reports showing that CARM1 and PRMT1 meth-termini play an important role in modulating
chromatin structure and function [1–3]. Lysine ylate histones in vitro and contain transcriptional coactiva-
tor function suggest that histones are potential physiologi-methylation of histones has been well documented
[4, 5], and recently this modification has been linked cal targets for arginine methylation [10, 12]. However,
clear evidence for the existence of arginine methylationto cellular processes involving gene transcription
and heterochromatin assembly [6–9]. However, the on histones has been lacking [13]. To identify sites of
arginine methylation on mammalian histones in vivo, weexistence of arginine methylation on histones has
remained unclear. Recent discoveries of protein individually purified histones isolated from asynchronously
growing human 293T cells by reverse-phase high-perfor-arginine methyltransferases, CARM1 and PRMT1,
as transcriptional coactivators for nuclear receptors mance liquid chromatography (RP-HPLC), digested
themwith chymotrypsin, and examined the resulting pep-suggest that histones may be physiological targets
of these enzymes as part of a poorly defined tides by nano-HPLCmicroelectrospray ionization tandem
mass spectrometry [14]. Collision-activated dissociationtranscriptional activation pathway [10–12]. Here we
show by using mass spectrometry that histone H4, (CAD) spectra of human H4 N-terminal chymotryptic
peptides revealed the addition of a methyl group to theisolated from asynchronously growing human 293T
cells, is methylated at arginine 3 (Arg-3) in vivo. In Arg-3 residue and indicated NG-monomethylation (Figure
1a). The predicted b- and y-type ion series of the H4support, a novel antibody directed against histone
H4 methylated at Arg-3 independently demonstrates peptide in which Arg-3 is monomethylated are shown, and
underlined masses indicate those fragments identified inthe in vivo occurrence of this modification and
reveals that H4 Arg-3 methylation is highly the spectrum (Figure 1a). Furthermore, other CAD spec-
tra show H4 N-terminal peptides lacking methylation atconserved throughout eukaryotes. Finally, we
show that PRMT1 is the major, if not exclusive, H4 Arg-3 (data not shown); these results support the above
characterization and indicate that some but not all H4Arg-3 methyltransfase in human 293T cells. These
findings suggest a role for arginine methylation of molecules are methylated at Arg-3. While arginine resi-
dues are capable of being methylated at either or both ofhistones in the transcription process.
their two terminal guanidino nitrogen groups generating
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methylation on H4 in all histones tested with the excep-
tion of (1) Tetrahymena, which contains a divergent ex-
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Figure 1
Histone H4 is methylated at arginine 3 in vivo.
(a) RP-HPLC-purified H4 isolated from 293T
cells was digested with chymotrypsin, and the
resulting peptides were examined by
nanoHPLC microelectrospray ionization
tandem mass spectrometry. The doubly
charged Arg-3-methylated H4 peptide having
a mass-to-charge (m/z) ratio of 487.4 was
subjected to collision-activated dissociation.
The sequence of the peptide is inset; across
the top are predicted b-type ions, which
contain the amino terminus of the peptide,
and across the bottom are predicted y-type
ions, which contain the carboxyl terminus of
the peptide. Those ions observed in the
spectrum are underlined. Zeros indicate
ions generated by the loss of water; asterisks
indicate ions generated by the loss of
ammonia. The addition of 14 mass units
(CH3 –H) to the Arg-3 residue, as indicated
by the b3, y9, y8*, and y9* ions, indicates Arg-3
NG-monomethylation. No dimethylation of
Arg-3 was observed (data not shown). The
bracket indicates a region where intensity
was multiplied five times for better visualization
of identified ions. (b) Sequence alignment of
the H4 N terminus from multiple eukaryotic
species. The first residue in all species shown
with the exception of Tetrahymena is known
to be N-terminally blocked by acetylation
(indicated by “Ac-NH”). The asterisk indicates
the arginine residue found to be methylated
in vivo by mass spectrometry. (c) Unmodified
or Arg-3 methylated H4 1–9 peptides were
used for an ELISA analysis of an H4 Arg-3
methyl-specific rabbit antiserum (-H4
R3Me). (d) -H4 R3Me rabbit antiserum was
used for an immunoblot analysis of histones
isolated from multiple eukaryotic species. Total
core histones from the species indicated (5
g) along with 1 g of recombinant Xenopus
H4 (a sequence that is identical to chicken
and human H4; Figure 1b) were resolved on
a 15% SDS-PAGE, transferred to a PVDF
membrane support, and probed with the -H4
R3Me antibody (upper panel). We analyzed
identical samples in parallel and examined
them by Coomassie staining to monitor of
histone loading (lower panel).
treme amino-terminal H4 tail lacking Arg-3, and (2) re- methylate H4 in a mixture of free calf thymus histones
[10]. Purified recombinant GST-PRMT1 was incubatedcombinant Xenopus H4 (Figure 1d). Together with our
mass spectrometric analyses, these data suggest that the with core histones isolated from chicken, Tetrahymena,
and human 293T cells in the presence of S-Adenosyl-L--H4 R3Me antibody recognizes both mono- and dimeth-
ylarginine. These results clearly demonstrate the in vivo [methyl-3H] methionine (3H-AdoMet), and reaction prod-
ucts were analyzed by SDS-PAGE and fluorography. Theexistence of arginine methylation in a broad range of
eukaryotic histones. Given this conservation, H4 Arg-3 results showed that GST-PRMT1 efficiently methylates
chicken and human 293T H4 from a mixture of coremethylation may play an important role in histone metab-
olism. histones (Figure 2a). As expected, GST-PRMT1 was un-
able to methylate H4 from Tetrahymena (Figure 2a), and
this finding suggests that Arg-3 is the major, if not exclu-In an attempt to determine the identity of the H4 Arg-3
methyltransferase, we examined the substrate and site sive, site of PRMT1methylation under these assay condi-
tions (see below). No methylation of histones was ob-specificity of PRMT1, which was previously shown to
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Figure 2 (Figure 2b). In agreement, recombinant XenopusH4 (rH4),
incubated in the presence of GST-PRMT1, was strongly
methylated at Arg-3 by immunoblot analysis with the
-H4 R3Me antibody (Figure 2c). In contrast, rH4 from
reactions lacking GST-PRMT1 was not immunoreactive
(Figure 2c). Nano-HPLC microelectrospray ionization
mass spectrometric analyses of the identical reactions
above revealed that the exclusive methylation product at
Arg-3 was NG-monomethylarginine (data not shown), a
result consistent with that previously observed by mass
spectrometry on H4 isolated from human 293T cells (see
Figure 1a). No dimethylarginine was detected by mass
spectrometry on rH4 after methylation in vitro by GST-
PRMT1 under our assay conditions.
Next, we sought to determine if PRMT1 is responsible
for mediating H4 Arg-3 activity in human 293T cells.
Initially, we asked if ectopically expressed PRMT1 iso-
lated from these cells retained the same substrate specific-
ity for H4 as seen with recombinant PRMT1. To that
end, HA-tagged PRMT1 (HA-PRMT1 wt), HA-tagged
PRMT1mutant (HA-PRMT1mut), which lacks the puta-
tive AdoMet binding site, or the parent vector (HA) were
ectopically expressed in human 293T cells; nuclear isola-
tion and DNase I extraction followed. We then used
chicken core histones and either AdoMet or 3H-AdoMet to
perform histonemethyltransferase (HMT) assays with these
extracts. The assays revealed that nuclear extracts fromHA-
PRMT1-expressing cells incorporated more 3H-AdoMet
PRMT1 selectively methylates arginine 3 of H4. (a) Histones isolated on H4 than extracts from either HA-PRMT1 mutant- or
from cells of several eukaryotic species were reacted in the presence HA-expressing cells (Figure 3a). Furthermore, immu-of purified GST-PRMT1 and 3H-AdoMet. Reactions were analyzed on
noblots probed with the -H4 R3Me antibody showeda 15% SDS-PAGE, and examination by Coomassie staining (lower
panel) or fluorography (upper panel) followed. The asterisk indicates that this activity is specific for histone H4 Arg-3 (Figure
H2A methylation. (b) RP-HPLC-purified H4 isolated from GST-PRMT1- 3a). Immunoprecipitations of the same nuclear extracts
labeled chicken core histones was deblocked and subjected to with an HA-specific antibody directly demonstrate thatN-terminal automated sequencing. A portion of each cycle was used
the enhancedH4Arg-3methyl activity observed in Figurefor amino acid identification by RP-HPLC, while the remainder was
3a is a result of HA-PRMT1 expression (Figure 3b).counted for 3H radioactivity. The arrow indicates the arginine residue
found to be methylated. (c) Recombinant Xenopus H4 (rH4) reacted These results indicate that cellular-derived PRMT1 can
in the presence or absence of purified GST-PRMT1 along with AdoMet directly and specifically methylate Arg-3 on H4. Further-
was immunoblotted as described in Figure 1 by the use of -H4
more, given that expressed HA-PRMT1 is extracted byR3Me rabbit antiserum (upper panel). We performed identical
DNase I digestion, these data also suggest that PRMT1reactions in parallel and examined them by Coomassie staining to
monitor rH4 loading (lower panel). is chromatin associated. In support, we note that the ex-
pression of HA-PRMT1 enhances nucleosomal H4 Arg-3
methylation activity that is detectable in 293T DNase I
nuclear extracts (data not shown). Although recombinantserved in the absence of GST-PRMT1 (Figure 2a). Under
or cellular PRMT1 can methylate H2A (as indicated bythese reaction conditions, mammalianH2Awas also found
asterisks in Figures 2a and 3b,c), this methylation is notto be weakly methylated (Figure 2a), a result consistent
detected by the -H4 R3Me antibody (Figure 3b). Thiswith earlier findings [10].
finding suggests that the-H4R3Me antibody is selective
for H4 Arg-3 methylation.To determine definitively which arginine residue(s) in
the H4 amino terminus is methylated by PRMT1, RP-
HPLC-purified H4 from labeling reactions with purified Since H4 Arg-3 methylation activity was detected in 293T
control DNase I extracts (see Figure 3a), we next wantedGST-PRMT1 and chicken core histones was microse-
quenced, and 3H incorporation associated with each cycle to determine if this activity was due to endogenous
PRMT1. To directly test this idea, we immunodepletedwas determined. Microsequence analysis showed that
Arg-3 is the exclusive site of methylation in the H4 tail endogenous PRMT1 from DNase I nuclear extracts and
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Figure 3
H4 Arg-3 methylation in human 293T cells is
mediated by PRMT1. (a) 293T cells were
transiently transfected with either parent
vector (HA), HA-PRMT1 putative AdoMet
binding mutant (HA-PRMT1 mut), or wild-type
HA-PRMT1 (HA-PRMT1 wt) expression
construct. This was followed by nuclear
isolation and DNase I extraction. HMT assays
with these DNase I extracts were performed
with 2 g of chicken core histones in the
presence of either radiolabeled or
nonradiolabeled AdoMet and analyzed, as
previously described, by fluorography or
immunoblots, respectively. Expression of HA-
PRMT1 mut and wild-type HA-PRMT1 was
monitored by immunoblotting with a
monoclonal -HA antibody. (b) DNase I
extracts from transfected cells as described
above were immunoprecipitated with an -HA
antibody, and immunoprecipitations were
assayed for 3H-methyl and H4 Arg-3-specific
HMT activity as described in Figure 2. (c)
Immunodepletion of endogenous PRMT1
leads to the removal of H4 Arg-3 methylation
activity. 293T DNase I extracts were incubated
in the presence of protein G-sepharose with analyzed for both 3H-methyl and H4 Arg-3- only versus beads plus addition of -PRMT1)
or without -PRMT1 followed by specific HMT activity as described above. were assayed for 3H-methyl HMT activity.
immunoprecipitation. Supernatants were Pellets from these immunoprecipitates (beads Asterisks indicate H2A-specific methylation.
assayed for any remainingH4methylation activity. Immu- eral transcription-related histone acetyltransferases have
been shown to bind selectively to acetylated histonesnodepletion of PRMT1 resulted in a nearly complete
abolishment of H4 Arg-3 methylation activity in these [17]. These data suggest that H4 Arg-3 methylation may
function through selective recruitment of a yet-unidenti-extracts (Figure 3c) and indicated that PRMT1 is the
major, if not exclusive, H4 Arg-3 HMT from human 293T fied factor(s). In addition, H4 Arg-3 methylation might
also function in transcription by influencing adjacentmod-cells. Furthermore, we show that immunoprecipitated
PRMT1 from the above immunodepleted assay retained ifications on the H4 amino terminus, such as serine 1
phosphorylation and/or lysines 5, 8, 12, and 16 acetylationessentially all of the H4 HMT activity (Figure 3c).
[4, 18]. Recent studies onH3 suggest that adjacentmodifi-
cations can influence transcription [19] and other cellularIn sum, our data clearly establish the in vivo existence of
arginine methylation on histone H4. Furthermore, we processes [20]. For example, serine 10 phosphorylation
coexists and is synergistic with lysine 14 acetylation inshow, by using a novel Arg-3 H4 methylation-specific
antibody, that thismodification is highly conserved among the mitogenic response [19, 21]. In contrast, serine 10
phosphorylation is inhibited by lysine 9 methylation ineukaryotes. Finally, strong evidence is provided that
PRMT1 is the responsible activity for H4 Arg-3 methyla- heterochromatin [20]. Future studies, then, should shed
light on how H4 Arg-3 methylation elicits meaningfultion in mammalian cells. Our data are consistent with
recent reports showing that PRMT1 is responsible for the downstream responses.
majority of nuclear arginine (type I) methylation activity
found in mammalian cells [15, 16] Given its role as a Supplementary material
Materials and methods with additional references are available at http://nuclear receptor coactivator [12], our data suggest that
images.cellpress.com/supmat/supmatin.htm.PRMT1 has an important role in regulating gene activity
throughmethylation of the H4 amino terminus. However,
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